Patient P-01871
Therapy response
Stable
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
25%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S16
- Day 10 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 14 HY-01 recommended — Hydration Protocol HY-01
- Day 15 Patient accepted — Started HY-01 in the companion
- Day 19 No meaningful change — Hydration Protocol HY-01
What changed?
Trajectory began diverging from predicted response on Day 10.
Primary contributors, last 14 days
- GI instability+8
- Inflammatory activity+5
- Nutritional resilience-3
What helped?
- Hydration Protocol HY-01Day 14Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients.
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↑60
- DNAIL6 -174 variant raises baseline inflammatory tone
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 32 ms, trending down
- Autonomic recovery ↓45
- WearableResting HR 79 bpm
- Wearable3,832 steps/day
- Butyrate / short-chain fatty acid production ↓35
- MicrobiomeButyrate capacity 39/100
- Drug metabolism and exposure ↑35
- DNADPYD *2A → slower clearance
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
DNA
Fictional pharmacogenomic panel
- IL6 -174 G/CHigher inflammatory tone
- DPYD *2A heterozygousSlower drug clearance
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 1.9 · butyrate capacity 39/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 34 ms
- Sleep
- 7.4 h
- Steps
- 4,038
- Resting HR
- 74 bpm
Daily log: GI score 25, nutritional resilience 65, adherence 93.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-01593 | 52% | S10 | HY-01 | improved | 56 |
| P-01342 | 51% | S11 | DT-01 | improved | 48 |
| P-01346 | 51% | S12 | DT-01 | improved | 52 |
| P-01585 | 50% | S13 | — | — | 49 |
| P-01701 | 50% | S11 | — | — | 55 |
| P-01787 | 50% | S19 | — | — | 51 |
| P-01519 | 49% | S06 | — | — | 48 |
| P-01823 | 49% | S01 | — | — | 57 |
| P-01633 | 47% | S16 | GI-04 | no change | 55 |
| P-01884 | 47% | S19 | GI-04 | no change | 54 |
| P-01381 | 46% | S12 | — | — | 68 |
| P-01818 | 46% | S15 | — | — | 46 |